Related Experiment Video
Updated: Oct 6, 2025

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Systematic Identification and Critical Appraisal of Pediatric COVID-19 Guidelines Applicable in India
Kamal Kumar Singhal1, Joseph L Mathew2, Jeanne M Dsouza3
1Department of Pediatrics, Advanced Pediatrics Center, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India.
Insights
Pediatric COVID-19 guidelines in India show low methodological quality, impacting their reliability and use. Urgent improvements are needed to enhance these critical health documents.
Area of Science:
- Pediatric infectious disease management
- Health guideline development and appraisal
- Public health policy in India
Background:
- The COVID-19 pandemic necessitated rapid development of pediatric management guidelines.
- Assessing the quality of these guidelines is crucial for ensuring effective and safe patient care.
- Limited information exists on the methodological rigor of pediatric COVID-19 guidelines specific to India.
Purpose of the Study:
- To systematically identify and critically appraise the methodological quality of pediatric guidelines for COVID-19 management in India.
- Evaluate the adherence of these guidelines to established quality standards.
Main Methods:
- Systematic literature search across ten databases for pediatric COVID-19 guidelines applicable to India (up to April 30, 2021).
- Methodological quality appraisal using the Appraisal of Guidelines for Research & Evaluation II (AGREE-II) tool by at least two independent appraisers.
- Statistical analysis of AGREE-II scores, comparing Indian vs. foreign, updated vs. original, and early vs. late pandemic guidelines.
Main Results:
- 62 guidelines were identified; only 8 (12.9%) were Indian.
- Overall AGREE-II scores indicated low methodological quality (median 37.9%).
- Domain scores revealed significant variability, with particularly low scores for Rigor of Development (23.4%) and Editorial Independence (8.3%).
- No significant differences in quality were found between Indian and foreign, updated and original, or early and late pandemic guidelines.
Conclusions:
- Available pediatric COVID-19 guidelines in India exhibit low methodological quality, compromising their credibility, validity, and applicability.
- Urgent strategies are required to improve the development and quality of these essential clinical guidelines.
- Enhancing guideline quality is paramount for ensuring optimal pediatric care during public health emergencies.
Objective:
To systematically identify and critically appraise the methodological quality of pediatric guidelines applicable to management of COVID-19 in India.
Methods:
Pediatric COVID-19 guidelines applicable to India, published until 30 April 2021, were identified through a systematic search across ten databases. Each was critically appraised for methodological quality using the AGREE-II tool, by at least two appraisers. Median (interquartile range) of the total score and domain-wise scores were calculated, and compared for Indian vs. foreign guidelines, updated vs. original versions of guidelines, and those developed earlier vs. later in the pandemic.
Results:
A total of 62 guidelines was identified. Only 8 (12.9%) were published in India. The overall AGREE-II score ranged from 4.7% to 72.8%; with median (IQR) 37.9% (29.4, 48.6). This suggested overall low(er) methodological quality. The median (IQR) domain-wise scores were as follows: Scope and Purpose 66.7% (58.3, 83.3), Stakeholder Involvement 41.7% (30.6, 83.3), Rigor of Development 23.4% (14.8, 37.5), Clarity of Presentation 59.7% (50.0, 75.0), Applicability 27.1% (18.8, 33.3), and Editorial Independence 8.3% (0.0, 45.8). This suggested diversity in quality of different aspects of the guidelines, with very low quality in the critical domain of methodological rigor. There were no statistically significant differences in the overall scores of Indian vs. foreign guidelines, updated versions vs. original versions, and those developed earlier vs. later in the pandemic.
Conclusion:
The currently available pediatric COVID-19 guidelines have low methodological quality, adversely affecting their credibility, validity, and applicability. Urgent corrective strategies are presented for consideration.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Distribution

